Michael Davis

Michael Davis is a member of Davis Polk's Corporate Department, practicing in the Mergers and Acquisitions and Private Equity Groups. His experience includes a wide variety of U.S. and international mergers and acquisitions transactions, including the following:

• Crestview Partners in connection with various transactions, including its investments in Select Energy Services, ValueOptions, Martin Currie and its acquisition of Key Safety Systems
• Toyo Seikan on its acquisition of Stolle Machinery Company from GSO Capital Partners LP
• Odebrecht Oil & Gas on a $400 million investment by Temasek
• Thomas & Betts on its proposed acquisition by ABB
• Cigna on its acquisition of HealthSpring
• FrontPoint Partners on its sale to Morgan Stanley, and the subsequent restructuring of Morgan Stanley's relationship with FrontPoint Partners
• Charles River on its proposed cross-border acquisition of WuXi PharmaTech
• Warner Chilcott on various transactions, including its acquisition of Procter & Gamble's prescription pharmaceuticals business, its acquisition of product rights from Novartis, its sale of product rights to LEO Pharma, and on the amendment to its global collaboration agreement with sanofi-aventis
• Citigroup on various transactions, including the sale of its auto loan business to Santander, its $306 billion loss sharing program with the U.S. government, and its 2009 $52.5 billion capital realignment
• Various other private equity and venture capital transactions

Michael is currently based in Davis Polk's New York office. He worked at Davis Polk's London office from 2003-2004. He is a member of the New York City Bar Committee on Mergers, Acquisitions & Proxy Contests.